Clinical applications of programmed electrical stimulation of the heart.

Clinical applications of programmed electrical stimulation of the heart. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Clinical applications of programmed electrical stimulation of the heart. Abstract Text:

P Brugada,L Mont,E Andries,

Clinical applications of programmed electrical stimulation of the heart. Publishing Authors By Initials

P Brugada,L Mont,E Andries,

For similar diagnosis: prognosis research abstracts see: diagnosis: prognosis research

PUBMED ID PMID:

MEDLINE DATE:

Clinical applications of programmed electrical stimulation of the heart. Journal Published:

PUBLICATION TYPE: Review

Journal: The Canadian journal of cardiology

VOLUME: 6

Page Numbers: 373-9

Journal Abbreviation:

ISSN: 1916-7075

DAY: 3

MONTH: Oct

YEAR: 1990

Clinical applications of programmed electrical stimulation of the heart. Information

Number of References: 38

LANGUAGE: eng

NlmUniqueID: 8510280

Clinical applications of programmed electrical stimulation of the heart. Keywords Mesh Terms:

KEYWORDS: Prognosis

MESH TERMS: therapy

Chemical & Substance for Abstract: Clinical applications of programmed electrical stimulation of the heart. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Clinical applications of programmed electrical stimulation of the heart.

AFFILIATION: Cardiovascular Center, OLV Hospital, Aalst, Belgium.

Country: CANADA

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Can J Cardiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Clinical applications of programmed electrical stimulation of the heart Related Publications

• Clinical applications of programmed electrical stimulation of the heart.
• Combined use of phage typing, enterococcinotyping and species differentiation of group D streptococci as an effective epidemiological tool.
• Establishment of a typing system for group D streptococci.
• Impact of the interaction of R207910 with rifampin on the treatment of tuberculosis studied in the mouse model.
• Prevention of drug carryover effects in studies assessing antimycobacterial efficacy of TMC207.
• [Typing of Streptococcus faecalis and Streptococcus faecium strains with bacteriophages]